About the PMPRB

The PMPRB protects and informs Canadians by ensuring that the prices of patented medicines sold in Canada are not excessive and by reporting on pharmaceutical trends.

Generics360 - 2016

Generics360 – Generic Drugs in Canada, 2016

The most recent edition of the Generics360 report examines the latest trends in domestic and international generic drug pricing, sales and utilization.

Find out more…

PMPRB Guidelines Scoping Paper

The PMPRB today published a scoping paper which provides its initial thoughts on how best to operationalize the Minister of Health’s proposed amendments to the Patented Medicines Regulations, which were published in the Canada Gazette, Part I on December 2, 2017.

Find out more…

Formularies Report

Alignment among Public Formularies in Canada - Part 1: General Overview

Study finds significant overlap in the drugs covered by Canadian public drug plans

Find out more…

Strategic Plan 2015-2018

PMPRB Strategic Plan – 2015-2018

The PMPRB’s three-year Strategic Plan includes four new strategic objectives, a reinvigorated mission statement, and a vision as to how the organization can work with partners and stakeholders in advancing the common goal of a sustainable health system.

Find out more…

Now available: Public submissions

Feedback submitted during Phase 1 of the Rethinking the Guidelines consultation initiative is now available.

Find out more…

I am a/an...

Consumer

Patentee

Other Stakeholder

Features

Annual Report 2016

Annual Report

PMPRB NEWSletter

Analytical Studies

Date modified: